Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 23, 2014 - Issue 11
Submit an article Journal homepage
297
Views
13
CrossRef citations to date
0
Altmetric
Drug Evaluations

Dovitinib: rationale, preclinical and early clinical data in urothelial carcinoma of the bladder

Clarisse R MazzolaWestern University, Division of Urology and Division of Surgical Oncology, London, Ontario, Canada+519 685 8451; +519 685 8455; [email protected]
,
Khurram M SiddiquiWestern University, Division of Urology and Division of Surgical Oncology, London, Ontario, Canada+519 685 8451; +519 685 8455; [email protected]
,
Michele BilliaWestern University, Division of Urology and Division of Surgical Oncology, London, Ontario, Canada+519 685 8451; +519 685 8455; [email protected]
&
Joseph ChinWestern University, Division of Urology and Division of Surgical Oncology, London, Ontario, Canada+519 685 8451; +519 685 8455; [email protected]
Pages 1553-1562 | Published online: 04 Oct 2014

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Carmine Valenza, Gabriele Antonarelli, Federica Giugliano, Gaetano Aurilio, Elena Verri, Alberto Briganti, Giuseppe Curigliano & Andrea Necchi. (2022) Emerging treatment landscape of non-muscle invasive bladder cancer. Expert Opinion on Biological Therapy 22:6, pages 717-734.
Read now

Articles from other publishers (12)

Andrea Franza, Marta Pirovano, Patrizia Giannatempo & Laura Cosmai. (2022) Erdafitinib in locally advanced/metastatic urothelial carcinoma with certain FGFR genetic alterations . Future Oncology 18:19, pages 2455-2464.
Crossref
Veronica Mollica, Francesco Massari, Alessandro Rizzo, Roberto Ferrara, Arjun K. Menta & Jacob J. Adashek. (2022) Genomics and Immunomics in the Treatment of Urothelial Carcinoma. Current Oncology 29:5, pages 3499-3518.
Crossref
Kamila Kitowska, Monika Gorska-Arcisz, Dima Antoun, Izabela Zarczynska, Dominika Czaplinska, Adrian Szczepaniak, Andrzej C. Skladanowski, Maciej Wieczorek, Aleksandra Stanczak, Monika Skupinska & Rafal Sadej. (2021) MET-Pyk2 Axis Mediates Acquired Resistance to FGFR Inhibition in Cancer Cells. Frontiers in Oncology 11.
Crossref
Sha Liu, Jiazhong Shi, Yuting Liu, Liwei Wang, Jingqi Zhang, Yaqin Huang, Zhiwen Chen & Jin Yang. (2021) Analysis of mRNA expression differences in bladder cancer metastasis based on TCGA datasets. Journal of International Medical Research 49:3, pages 030006052199692.
Crossref
Yuying Han, Xu Liu, Haihong Ye, Ye Tian & Zhengguo Ji. (2020) Lower mutant-allele tumor heterogeneity is a biomarker in FGFR3-mutant bladder cancer for better prognosis. World Journal of Surgical Oncology 18:1.
Crossref
Jaegil Kim, Gordon Robertson, Rehan Akbani, Seth P. Lerner, John N. Weinstein, Gad Getz & David J. Kwiatkowski. 2018. Precision Molecular Pathology of Bladder Cancer. Precision Molecular Pathology of Bladder Cancer 43 64 .
J.L. Chin, K.M. Siddiqui & K.-C. Tran. 2017. Introduction to Cancer Metastasis. Introduction to Cancer Metastasis 177 198 .
D. Pouessel, Y. Neuzillet, L.S. Mertens, M.S. van der Heijden, J. de Jong, J. Sanders, D. Peters, K. Leroy, A. Manceau, P. Maille, P. Soyeux, A. Moktefi, F. Semprez, D. Vordos, A. de la Taille, C.D. Hurst, D.C. Tomlinson, P. Harnden, P.J. Bostrom, T. Mirtti, S. Horenblas, Y. Loriot, N. Houédé, C. Chevreau, P. Beuzeboc, S.F. Shariat, A.I. Sagalowsky, R. Ashfaq, M. Burger, M.A.S. Jewett, A.R. Zlotta, A. Broeks, B. Bapat, M.A. Knowles, Y. Lotan, T.H. van der Kwast, S. Culine, Y. Allory & B.W.G. van Rhijn. (2016) Tumor heterogeneity of fibroblast growth factor receptor 3 (FGFR3) mutations in invasive bladder cancer: implications for perioperative anti-FGFR3 treatment. Annals of Oncology 27:7, pages 1311-1316.
Crossref
Chun-Han Chen, Yi-Min Liu, Shiow-Lin Pan, Yun-Ru Liu, Jing-Ping Liou & Yun Yen. (2016) Trichlorobenzene-substituted azaaryl compounds as novel FGFR inhibitors exhibiting potent antitumor activity in bladder cancer cells in vitro and in vivo . Oncotarget 7:18, pages 26374-26387.
Crossref
Yanina V. Langle, Denise Belgorosky, B?rbara Prack McCormick, Ana Sahores, Adri?n G?ngora, Alberto Baldi, Claudia Lanari, Caroline Lamb & Ana M. Eij?n. (2016) FGFR3 Down-Regulation is Involved in bacillus Calmette-Gu?rin Induced Bladder Tumor Growth Inhibition. The Journal of Urology 195:1, pages 188-197.
Crossref
Jaegil Kim, Rehan Akbani, Chad J. Creighton, Seth P. Lerner, John N. Weinstein, Gad Getz & David J. Kwiatkowski. (2015) Invasive Bladder Cancer: Genomic Insights and Therapeutic Promise. Clinical Cancer Research 21:20, pages 4514-4524.
Crossref
Hermann AM Mucke. (2015) Patent Highlights. Pharmaceutical Patent Analyst 4:3, pages 141-146.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.